Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure

Journal of the American College of Cardiology

Volumn 44, Issue 1, 2004, Pages 63-67

  Van Der Meer, Peter ^a,c   Voors, Adriaan A ^a   Lipsic, Erik ^a,b   Smilde, Tom D J ^a   Van Gilst, Wiek H ^b   Van Veldhuisen, Dirk J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c 9700 the ^*  (Netherlands)

Author keywords

BNP; brain natriuretic peptide; CHF; chronic heart failure; CI; confidence interval; EPO; erythropoietin; GFR; glomerular filtration rate; hazard ratio; Hb; hemoglobin; HR; left ventricular; left ventricular ejection fraction; LV; LVEF; New York Heart Association; NYHA

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; ERYTHROPOIETIN;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHRONIC DISEASE; ERYTHROPOIETIN; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NETHERLANDS; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS; SURVIVAL ANALYSIS;

EID: 3242799671     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.03.052     Document Type: Article

References (20)

1. Cromie N., Lee C., Struthers A.D. Anaemia in chronic heart failure what is its frequency in the UK and its underlying causes? Heart. 87:2002;377-378
2. Horwich T.B., Fonarow G.C., Hamilton M.A., MacLellan W.R., Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol. 39:2002;1780-1786
3. Mozaffarian D., Nye R., Levy W.C. Anemia predicts mortality in severe heart failure the Prospective Randomized Amlodipine Survival Evaluation (PRAISE). J Am Coll Cardiol. 41:2003;1933-1939
4. Silverberg D.S., Wexler D., Blum M., et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol. 35:2000;1737-1744
5. Ezekowitz J.A., McAlister F.A., Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes insights from a cohort of 12,065 patients with new-onset heart failure. Circulation. 107:2003;223-225
6. Jacobson L.O., Goldwasser E., Fried W., Plzak L. Role of the kidney in erythropoiesis. 1957. J Am Soc Nephrol. 11:2000;589-590
7. Lorentz A., Eckardt K.U., Osswald P.M., Duchow J.R. Erythropoietin levels in patients depositing autologous blood in short intervals. Ann Hematol. 64:1992;281-285
8. Volpe M., Tritto C., Testa U., et al. Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles. Am J Cardiol. 74:1994;468-473
9. Chatterjee B., Nydegger U.E., Mohacsi P. Serum erythropoietin in heart failure patients treated with ACE inhibitors or AT(1) antagonists. Eur J Heart Failure. 2:2000;393-398
10. Remme W.J., Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 22:2001;2217-2218
11. Benson E.W., Hardy R., Chaffin C., Robinson C.A., Konrad R.J. New automated chemiluminescent assay for erythropoietin. J Clin Lab Analysis. 14:2000;271-273
12. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron. 16:1976;31-41
13. Hillege H.L., Girbes A.R., de Kam P.J., et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 102:2000;203-210
14. Robertshaw M., Lai K.N., Swaminathan R. Prediction of creatinine clearance from plasma creatinine comparison of five formulae. Br J Clin Pharmacol. 28:1989;275-280
15. Al-Ahmad A., Rand W.M., Manjunath G., et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 38:2003;955-962
16. Kalra P.R., Collier T., Cowie M.R., et al. Haemoglobin concentration and prognosis in new cases of heart failure. Lancet. 362:2003;211-212
17. Silverberg D.S., Wexler D., Iaina A. The importance of anemia and its correction in the management of severe congestive heart failure. Eur J Heart Failure. 4:2002;681-686
18. Van der Meer P., Voors A.A., Lipsic E., van Gilst W.H., Van Veldhuisen D.J. Erythropoietin in cardiovascular diseases. Eur Heart J. 25:2004;285-291
19. Silverberg D.S., Wexler D., Sheps D., et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron a randomized controlled study. J Am Coll Cardiol. 37:2001;1775-1780
20. Mancini D.M., Katz S.D., Lang C.C., LaManca J., Hudaihed A., Androne A.S. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation. 107:2003;294-299